All Pathways
NeurosurgeryManagement

Malignant MCA Stroke - Decompressive Hemicraniectomy Decision

Malignant MCA Stroke - Decompressive Hemicraniectomy Decision: Large MCA Territory Stroke → Confirm Malignant Features → Patient Age? → Age ≤60 Years → ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Large MCA Territory Stroke

    CT/MRI showing ≥50% MCA territory infarction with developing edema

    1. Action

      Confirm Malignant Features

      Imaging criteria for malignant MCA infarction

      • Infarct ≥50% MCA territory on CT/DWI
      • Volume >145 mL on DWI (ESCAPE criteria)
      • Signs of early edema/sulcal effacement
      • Midline shift developing
      1. Decision

        Patient Age?

        Age stratification affects recommendations

        1. Action

          Age ≤60 Years

          Strong evidence for benefit (AHA Class IIa, LOE A)

          • Pooled analysis: mortality 22% vs 71% (NNT=2)
          • mRS ≤4 at 1 year: 75% vs 24%
          • mRS ≤3 at 1 year: 43% vs 21%
          • DECIMAL, DESTINY, HAMLET trials
          1. Decision

            Time from Symptom Onset <48h?

            Surgical window based on trial criteria

            1. Action

              Within Surgical Window

              Proceed with evaluation for surgery

              1. Decision

                Clinical Criteria Met?

                Assess neurological status

                • NIHSS ≥15 (or >20 for dominant hemisphere)
                • GCS ≥6 (most trials)
                • Decline in consciousness (GCS drop)
                • New pupillary changes
                1. Decision

                  Any Contraindications?

                  Assess for absolute/relative contraindications

                  • Pre-stroke mRS ≥2 (functional dependence)
                  • Terminal illness
                  • Coagulopathy (correct first)
                  • Bilateral fixed pupils (controversial)
                  1. Action

                    Goals of Care Discussion

                    Family/surrogate decision-making

                    • Explain survival vs disability trade-off
                    • Most survivors have moderate-severe disability
                    • Quality of life assessment
                    • Patient's known wishes if available
                    • Shared decision-making essential
                    1. Action

                      Proceed to Hemicraniectomy

                      Decompressive surgery

                      • Bone flap ≥12 cm diameter
                      • Duraplasty (dura opened and expanded)
                      • No hematoma evacuation needed
                      • Bone flap stored for later cranioplasty
                      1. Action

                        Post-Operative Care

                        ICU management after hemicraniectomy

                        • Continue ICP monitoring if needed
                        • DVT prophylaxis after hemostasis
                        • Early nutrition
                        • Cranioplasty typically at 6-12 weeks
                        1. Outcome

                          Surgical Outcome

                          Expected: reduced mortality, but significant disability likely

                    2. Action

                      Conservative/Medical Management

                      If surgery not pursued

                      • ICP management (osmotherapy, positioning)
                      • Comfort-focused care if appropriate
                      • ICU monitoring
                      • May reconsider if condition changes
                      1. Outcome

                        Conservative Outcome

                        Continue supportive care; high mortality without surgery

            2. Warning

              ⚠️ Beyond 48h Window

              Limited evidence beyond 48h

              • Trial data limited to <48h
              • Consider on case-by-case basis
              • May still benefit if herniation imminent
              • Discuss with neurosurgery
        2. Action

          Age >60 Years

          DESTINY II showed survival benefit but higher disability

          • DESTINY II: survival 43% vs 17%
          • mRS ≤4: 38% vs 18% at 6 months
          • BUT: most survivors have mRS 4-5
          • Goals of care discussion critical

Guideline Source

AHA/ASA 2019 Guidelines for Early Management of Acute Ischemic Stroke + DESTINY/DECIMAL/HAMLET Trials Pooled Analysis

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Quality of life outcomes must be discussed with family
  • Patients >60 have higher mRS despite survival benefit
  • Does not address dominant hemisphere considerations fully
  • Posterior circulation strokes excluded
  • Requires multidisciplinary discussion

Applicable Regions

USEUGlobal

EU: ESO guidelines compatible, European trials (DESTINY, DECIMAL, HAMLET)

US: AHA/ASA Class IIa recommendation for age <60

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Malignant MCA Stroke - Decompressive Hemicraniectomy Decision?

The Malignant MCA Stroke - Decompressive Hemicraniectomy Decision is a management clinical algorithm for Neurosurgery. It provides a structured decision tree to guide clinical decision-making, based on AHA/ASA 2019 Guidelines for Early Management of Acute Ischemic Stroke + DESTINY/DECIMAL/HAMLET Trials Pooled Analysis.

What guideline is the Malignant MCA Stroke - Decompressive Hemicraniectomy Decision based on?

This algorithm is based on AHA/ASA 2019 Guidelines for Early Management of Acute Ischemic Stroke + DESTINY/DECIMAL/HAMLET Trials Pooled Analysis (DOI: 10.1161/STR.0000000000000211).

What are the limitations of the Malignant MCA Stroke - Decompressive Hemicraniectomy Decision?

Known limitations include: Quality of life outcomes must be discussed with family; Patients >60 have higher mRS despite survival benefit; Does not address dominant hemisphere considerations fully; Posterior circulation strokes excluded; Requires multidisciplinary discussion. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Malignant MCA Stroke - Decompressive Hemicraniectomy Decision appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free